Strategic Diversification: From COVID to Oncology Innovation After the global success of its COVID-19 vaccine, Pfizer is strategically shifting...
Category: Asset
Oncology Breakthroughs: Expanding Beyond Keytruda® Merck’s oncology pipeline is rapidly evolving beyond its flagship immunotherapy, Keytruda®,...
Accelerating AI Infrastructure Orders and Revenue Growth As artificial intelligence (AI) continues to reshape industries, the demand for robust,...